Volume 9; Issue 4

The Pharmacogenomics Journal

Volume 9; Issue 4

1

Global variation in CYP2C8–CYP2C9 functional haplotypes

Speed, William C, Kang, Soonmo Peter, Tuck, David P, Harris, Lyndsay N, Kidd, Kenneth K

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 451 KB

english, 2009

2

Association of nicotinic acetylcholine receptor subunit α4 polymorphisms with nicotine dependence in 5500 Germans

Breitling, L P, Dahmen, N, Mittelstraß, K, Rujescu, D, Gallinat, J, Fehr, C, Giegling, I, Lamina, C, Illig, T, Müller, H

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 156 KB

english, 2009

3

Genetic predictors of response to antidepressants in the GENDEP project

Uher, Rudolf, Huezo-Diaz, Patricia, Perroud, Nader, Smith, Rebecca, Rietschel, Marcella, Mors, Ole, Hauser, Joanna, Maier, Wolfgang, Kozel, Dejan, Henigsberg, Neven, Barreto, Mara, Placentino, Anna, D

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 166 KB

english, 2009

4

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

Becker, M L, Visser, L E, van Schaik, R H N, Hofman, A, Uitterlinden, A G, Stricker, B H C

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 109 KB

english, 2009

5

APOE gene polymorphisms and response to statin therapy

Zintzaras, E, Kitsios, G D, Triposkiadis, F, Lau, J, Raman, G

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 156 KB

english, 2009

6

A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients

Demacq, C, Vasconcellos, V B, Marcaccini, A M, Gerlach, R F, Machado, A A, Tanus-Santos, J E

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 340 KB

english, 2009

7

Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene

Godlewska, B R, Olajossy-Hilkesberger, L, Ciwoniuk, M, Olajossy, M, Marmurowska-Michałowska, H, Limon, J, Landowski, J

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 148 KB

english, 2009

8

A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo

Al Koudsi, Nael, Ahluwalia, Jasjit S, Lin, Shih-Ku, Sellers, Edward M, Tyndale, Rachel F

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 158 KB

english, 2009

9

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Rae, J M, Sikora, M J, Henry, N L, Li, L, Kim, S, Oesterreich, S, Skaar, T C, Nguyen, A T, Desta, Z, Storniolo, A M, Flockhart, D A, Hayes, D F, Stearns, V

Journal:

The Pharmacogenomics Journal

Année:

2009

Langue:

english

Fichier:

PDF, 135 KB

english, 2009